Cervical Myelopathy Diagnosis and Surgical Management

Cervical myelopathy arises when the spinal cord is compressed by degenerative changes in the cervical spine, leading to progressive neurological impairment. Early diagnosis relies on clinical recognition of gait disturbance, hand dysfunction and sensory alterations, supported by magnetic resonance imaging to delineate the site and severity of cord compression. Electrophysiological studies may supplement imaging by detecting functional impairment of spinal pathways. When conservative measures fail or when significant cord compromise is evident, surgical decompression is indicated. Approaches include anterior cervical discectomy and fusion, laminoplasty or posterior laminectomy, chosen according to the pattern of compression, alignment of the cervical spine and patient comorbidities. Timely surgery has been shown to halt progression of disability and, in many cases, to restore neurological function. Outcome prediction incorporates preoperative severity, symptom duration and patient factors, while emerging biomarkers and quantitative MRI techniques promise to refine patient selection and prognostication. A coordinated, multidisciplinary pathway from diagnosis through rehabilitation is essential to optimise recovery and long-term quality of life.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Cervical Myelopathy Diagnosis and Surgical Management publication trend

The graph below shows the total number of articles in cervical myelopathy diagnosis and surgical management across all publications each year (not limited to Nature Index journals).

Technical terms

Degenerative cervical myelopathy: Progressive spinal cord injury caused by age-related degeneration of cervical vertebrae and ligaments, leading to canal narrowing and neurological dysfunction.

Magnetic resonance imaging (MRI): Non-invasive imaging modality using magnetic fields and radiofrequency pulses to visualise soft tissues, essential for identifying cord compression and signal changes in myelopathy.

Core outcome set (COS): Agreed standardised collection of key outcomes that should be measured and reported in all clinical trials for a specific condition, enhancing comparability across studies.

Blood–spinal cord barrier (BSCB): Physiological barrier between the spinal cord microenvironment and the circulatory system, whose disruption can exacerbate injury and impede recovery after decompression.

Diffusion tensor imaging (DTI): Advanced MRI technique that quantifies the directional diffusion of water molecules in tissue, used to assess microstructural integrity of spinal cord white matter.

References

1. A minimum data set-Core outcome set, core data elements, and core measurement set-For degenerative cervical myelopathy research (AO Spine RECODE DCM): A consensus study.. PLOS Medicine (2024).
2. Cervical Myelopathy and Social Media: Mixed Methods Analysis. Journal of Medical Internet Research (2023).
3. Blood-spinal cord barrier disruption in degenerative cervical myelopathy. Fluids and Barriers of the CNS (2023).